|
1
|
White HD and Chew DP: Acute myocardial
infarction. Lancet. 372:570–584. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pfisterer ME, Zellweger MJ and Gersh BJ:
Management of stable coronary artery disease. Lancet. 375:763–772.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hansson GK: Inflammation, atherosclerosis
and coronary artery disease. N Engl J Med. 352:1685–1695. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Libby P and Theroux P: Pathophysiology of
coronary artery disease. Circulation. 111:3481–3488. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Samani NJ, Erdmann J, Hall AS, et al:
Genomewide association analysis of coronary artery disease. N Engl
J Med. 357:443–453. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Topol EJ, Smith J, Plow EF and Wang QK:
Genetic susceptibility to myocardial infarction and coronary artery
disease. Hum Mol Genet. 15:R117–R123. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nebert DW and Gonzalez FJ: P450 genes:
structure, evolution and regulation. Annu Rev Biochem. 56:945–993.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Whitlock JP Jr: Induction of cytochrome
P4501A1. Annu Rev Pharmacol Toxicol. 39:103–125. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sivaraman L, Leatham MP, Yee J, Wilkens
LR, Lau AF and Le Marchand L: CYP1A1 genetic polymorphisms and in
situ colorectal cancer. Cancer Res. 54:3692–3695. 1994.PubMed/NCBI
|
|
10
|
Landi MT, Bertazzi PA, Shields PG, et al:
Association between CYP1A1 genotype, mRNA expression and enzymatic
activity in humans. Pharmacogenetics. 4:242–246. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang XL, Greco M, Sim AS, Duarte N, Wang J
and Wilcken DE: Effect of CYP1A1 MspI polymorphism on cigarette
smoking related coronary artery disease and diabetes.
Atherosclerosis. 162:391–397. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Taspinar M, Aydos S, Sakiragaoglu O, et
al: Impact of genetic variations of the CYP1A1, GSTT1 and GSTM1
genes on the risk of coronary artery disease. DNA Cell Biol.
31:211–218. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Achour A, Zaag I, Gueddah L, Trimeche B,
Slama FB and Zemni R: Role of CYP1A1 (T6235C) polymorphism and
cigarette smoking in the development of coronary heart disease in
Tunisian population. J Genet. 90:303–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cornelis MC, El-Sohemy A and Campos H:
Genetic polymorphism of CYP1A2 increases the risk of myocardial
infarction. J Med Genet. 41:758–762. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Manfredi S, Federici C, Picano E, Botto N,
Rizza A and Andreassi MG: GSTM1, GSTT1 and CYP1A1 detoxification
gene polymorphisms and susceptibility to smoking-related coronary
artery disease: a case-only study. Mutat Res. 621:106–112. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yeh CC, Sung FC, Kuo LT, Hsu WP and Chu
HY: Polymorphisms of cytochrome P450 1A1, cigarette smoking and
risk of coronary artery disease. Mutat Res. 667:77–81. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stroup DF, Berlin JA, Morton SC, et al:
Meta-analysis of observational studies in epidemiology: a proposal
for reporting. Meta-analysis Of Observational Studies in
Epidemiology (MOOSE) group. JAMA. 283:2008–2012. 2000. View Article : Google Scholar
|
|
18
|
Wells G, Shea B, O’Connell D, et al: The
Newcastle-Ottawa Scale (NOS) for assessing the quality of
nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
Accessed September 14, 2012
|
|
19
|
Boivin J, Griffiths E and Venetis CA:
Emotional distress in infertile women and failure of assisted
reproductive technologies: meta-analysis of prospective
psychosocial studies. BMJ. 342:d2232011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Millett GA, Flores SA, Marks G, Reed JB
and Herbst JH: Circumcision status and risk of HIV and sexually
transmitted infections among men who have sex with men: a
meta-analysis. JAMA. 300:1674–1684. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rohlfs RV and Weir BS: Distributions of
Hardy-Weinberg equilibrium test statistics. Genetics.
180:1609–1616. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cochran WG: The combination of estimates
from different experiments. Biometrics. 10:101–129. 1954.
View Article : Google Scholar
|
|
23
|
Higgins JP, Thompson SG, Deeks JJ and
Altman DG: Measuring inconsistency in meta-analyses. BMJ.
327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–188. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mantel N and Haenszel W: Statistical
aspects of the analysis of data from retrospective studies of
disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
|
|
26
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jarvis MD, Palmer BR, Pilbrow AP, et al:
CYP1A1 MSPI (T6235C) gene polymorphism is associated with mortality
in acute coronary syndrome patients. Clin Exp Pharmacol Physiol.
37:193–198. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim SJ, Kim MG, Kim KS, Song JS, Yim SV
and Chung JH: Impact of glutathione S-transferase M1 and T1 gene
polymorphisms on the smoking-related coronary artery disease. J
Korean Med Sci. 23:365–372. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang XM, Xu G, Shan J, Jin GD, Huang CL
and Wu KS: Association of the MspI polymorphism of cytochrome
P4501A1 gene and smoking to the susceptibility to coronary artery
disease. Zhonghua Xin Xue Guan Bing Za Zhi. 35:536–539. 2007.(In
Chinese).
|
|
30
|
Nebert DW and Dalton TP: The role of
cytochrome P450 enzymes in endogenous signalling pathways and
environmental carcinogenesis. Nat Rev Cancer. 6:947–960. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Martucci CP and Fishman J: P450 enzymes of
estrogen metabolism. Pharmacol Ther. 57:237–257. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen C, Huang Y, Li Y, Mao Y and Xie Y:
Cytochrome P450 1A1 (CYP1A1) T3801C and A2455G polymorphisms in
breast cancer risk: a meta-analysis. J Hum Genet. 52:423–435. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang JJ, Zheng Y, Sun L, et al: CYP1A1
Ile462Val polymorphism and susceptibility to lung cancer: a
meta-analysis based on 32 studies. Eur J Cancer Prev. 20:445–452.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang M, Chen Q, Xiao J, Zhao X and Liu C:
CYP1A1 Ile462Val is a risk factor for ovarian cancer development.
Cytokine. 58:73–78. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Androutsopoulos VP, Tsatsakis AM and
Spandidos DA: Cytochrome P450 CYP1A1: wider roles in cancer
progression and prevention. BMC Cancer. 9:1872009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Peters J and Mengersen K: Selective
reporting of adjusted estimates in observational epidemiology
studies: reasons and implications for meta-analyses. Eval Health
Prof. 31:370–389. 2008. View Article : Google Scholar : PubMed/NCBI
|
